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Introduction: The saliva of hematophagous or blood-sucking insects 
contains different substances that allow obtaining and ingesting the 
blood of their vertebrate hosts without being detected. 
Objective: To explore the salivary compounds of hematophagous 
insects which have vasodilator, anticoagulant, anti-inflammatory, 
immunomodulatory and anesthetic properties, and that can be 
exploited due to their high pharmacological potential.
Materials and methods: A non-systematic literature review was 
done in PubMed, EMBASE, and ScienceDirect OvidSP; data was 
not limited by date, language nor item type. Articles on salivary 
compounds of blood-sucking insects, whose main topic was the 
effects on hemostasis, immunomodulation and drug use, were sought. 
59 articles met the criteria for inclusion in the review.
Conclusions: The saliva of hematophagous insects has a wide 
variety of molecules that constitute a source of research and have 
an incalculable potential for the discovery of compounds that could 
be pharmacologically useful.
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| Resumen |
Introducción. La saliva de los artrópodos hematófagos contiene un 
arsenal de compuestos que les permite acceder a la sangre de sus 
hospederos vertebrados sin ser detectados. 
Objetivo. Explorar los compuestos salivares de insectos hematófagos que 
tienen propiedades vasodilatadoras, anticoagulantes, antiinflamatorias, 
inmunomoduladoras y anestésicas, las cuales se pueden aprovechar por 
su alto potencial farmacológico.
Materiales y métodos. Se realizó una revisión no sistemática de 
la literatura mediante búsqueda electrónica en las bases de datos 
PubMed, EMBASE, OvidSP y ScienceDirect; la búsqueda no se 
limitó por fecha, idioma ni tipo de artículo. Se buscaron artículos 
sobre los compuestos salivares de los insectos hematófagos, cuyo 
tema central fuese los efectos en la hemostasia, inmunomodulación 
y uso farmacológico. Se encontraron 59 artículos que cumplían con 
los criterios para ser incluidos en la revisión. 
Conclusión. La saliva de los insectos hematófagos posee gran variedad 
de moléculas, lo que ofrece una fuente de investigación y un potencial 
incalculable para el descubrimiento de compuestos que podrían llegar 
a tener utilidad farmacológica. 
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Introduction
Hematophagy or feeding on blood has been seen in various taxa along 
the evolutionary tree. This is especially relevant in arthropods because 
they are vectors of different pathogens. Arthropods within the class 
Insecta or Hexapoda are among the most numerous and diverse of 
the animal kingdom, with almost 1 200 000 species described, which 
corresponds to 80% of all animals (1).
In general, the saliva of insects has several functions: digestion, 
water balance, antagonism of host defense systems, maintenance of 
the mouthparts, and secretion of pheromones; also, it is believed to 
have antimicrobial substances (2). Hematophagy is one of the many 
feeding habits that these species have, that is, they ingest vertebrate 
blood, including human blood. 
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Hematophagy is not unique to arthropods and occurs throughout 
the evolutionary scale; parasites such as Entamoeba histolytica 
and different species of Plasmodium consume blood or parts of its 
components. Leeches, Annelida phylum invertebrates and higher 
animals such as some species of bats of the Desmodontinae subfamily, 
better known by the name of vampires, also feed on blood.
Apparently, the ability to feed on vertebrate blood was developed 
during the Cretaceous period (3) in parallel to the early division of 
mammals and birds that replaced dinosaurs. One hypothesis of the 
evolution of hematophagy is that insects that lived very close to 
birds or mammals went from being detritivores to hematophagous, 
with a subsequent modification of the mouthparts, which means 
that the association between vertebrates and hematophagous insects 
induced coevolution. 
Hematophagy appeared independently during the evolution of 
arthropods and was only developed by 14 000 species, distributed 
among 400 different genera from more than one million species of 
insects (4). These numbers suggest that hematophagy presented 
mechanical and physiological difficulties during its evolution (5), 
since it involved the modification of the mouthparts to penetrate, 
cut and suck, in addition to the challenges for digesting and using 
blood for different processes related to growth and development or 
for the maturation of eggs. The detoxification of the heme group 
was also very important, for which they had to chelate it and thus 
produce hemozoin (5). 
Insects ingest the blood in two different ways: some take the 
blood directly from channel blood vessels —solenophagy— and 
others break the tissues and produce multiple wounds forming a pool 
of blood —telmophagy (6). In both cases, insects had to develop 
an arsenal of molecules with different effects, such as vasodilators, 
anticoagulants, antiplatelets, anti-inflammatories, immunomodulators, 
analgesics and, apparently, local anesthetics in order to counteract 
defenses and other responses of the hosts against the damage inflicted 
by the hematophagous animal (7).
However, not all haematophagous insects use blood for the same 
purposes. For example, insects such as Triatomines need blood to 
cover all physiological requirements, whereas some species of the 
Culicidae, Ceratopogonidae and Simuliidae families need blood only 
to mature the eggs —in this case the composition and morphology 
of the salivary glands are different in both sexes (8).
Vertebrates have three efficient defense systems that make 
hematophagy potentially difficult, which are hemostasis, inflammation 
mechanisms and immunity. With all of these factors in mind, insects 
may be potentially beneficial for the discovery of new molecules and, 
perhaps, new drugs.
Below, different molecules that have been found in the salivary 
glands of hematophagous insects are described, and some research 
developed on their applicability in medicine are summarized.
Vasodilators
Vasoconstriction is one of the first reflex mechanisms against bleeding 
and capillary damage; for this reason, hematophagous insects have 
developed various vasodilator molecules to ensure blood intake. Some 
examples of this type of substances include nitroporins, which are 
molecules with a heme group that reversibly bind to nitric oxide and 
are then released into the host to exert a vasodilator and antiplatelet 
effect. Nitroporins have been identified in Rhodnius prolixus (9) —
the main vector of Trypanosoma cruzi in Colombia—, are known as 
np1 and np4 and belong to the lipocalines group (10,11). They have 
also been identified in Cimex lectularius, or bed bug (12), but these 
nitroporines belong to the inositol phosphatases group (13).
In addition, ticks produce prostaglandins in large quantities; so 
far, PGE2 and PGF2 alpha have been identified (14,15). Diptera of 
the genus Phlebotomus produce adenosine, which is secreted by 
75-80% after initiating blood ingestion, and its vasodilatory and 
antiplatelet activity has been demonstrated (16,17). Insects of the 
genus Lutzomyia have a potent vasodilator, maxadilan, which binds to 
the PACAP receptor and has 500-fold more vasodilatory activity than 
the peptide related to the calcitonin gene, the most potent vasodilator 
compound known to date (18,19). Other examples of isolated and 
characterized vasodilator molecules are type I and II sialokinins found 
in Aedes aegypti (20,21).
The species Simulium vittatum belongs to the Simuliidae family 
—known in Colombia as jején, mosquito,  among others— and has a 
15-kDa protein called Simulium vittatum erythema protein or SVEP 
in its saliva, which increases the perfusion of blood in the cutaneous 
capillaries and triggers the erythema associated with the insect bite. 
Apparently, its vasodilation mechanism relaxes smooth muscles, 
since it stimulates the opening of K+ channels that dependend on 
ATP (22,23). 
Finally, a peroxidase has been identified in the female Anopheles 
albimanus, one of the three main vectors of malaria in Colombia, 
which exerts its vasodilatory effect by destroying norepinephrine 
and serotonin (24).
Anticoagulants
Hemostasis, a mechanism used by animals as a response to tissue 
damage, involves three processes: platelet aggregation, coagulation 
and vessel constriction. This mechanism represents a major challenge 
for hematophagous animals, since thrombin inhibitors have multivalent 
reactions in common, which results in high specificity and affinity, 
besides of blocking interactions with possible substrates and cofactors. 
One of the best inhibitors of hematophagous animals is hirudin, extracted 
from the Hirudo medicinalis leech, although other serine proteases with 
the same function have also been found in other leeches (25). 
Anti-hemostatic molecules show the great diversity of compounds 
derived from the saliva of hematophagous animals. For example, 
apyrase belongs to a family of enzymes that hydrolyze ATP and 
ADP to yield AMP, and that may have an anti-inflammatory and 
antihemostatic effect (26-27). These molecules can be found in 
various insects such as Aedes aegypti (28), vector of some flaviviruses 
including dengue, zika and chikungunya in Colombia; Lutzomyia 
longipalpis, vector of Leishmania infantum in many Latin American 
regions (29); Phlebotomus papatasi, vector of Leshmania donovani 
in the Old World and of bedbugs (30), and Cimex lectularius (31) 
and Ayadualina extracted from the salivary glands of Lutzomyia 
ayacuyensis, whose function is to inhibit collagen-induced platelet 
aggregation and ADP (32). Higher concentrations of heparin have 
been found in the midgut of Aedes togoi, which is related to the 
salivary glands of females who have ingested blood (33). An isolated 
Factor Xa inhibitor, characterized and known as anticoagulant Factor 
Xa (AFXa), belongs to the superfamily of serpins and can be found 
in Aedes aegypti (34,35). 
Several thrombin inhibitor compounds such as Mandanin-1 and 
Mandanin-2 —competitive inhibitors of thrombin and extracted from 
the saliva of the tick Longicornis haemaphysalis— (36) have been 
recently discovered. Other examples of thrombin inhibitors include 
the Americanin molecule, obtained from the salivary glands of the 
tick Amblyomma americanum (37); the Anopheline molecule from the 
Anopheles albimanus mosquito (38,39), and the CE5 protein found 
in Anopheles gambiae (40), and  AaTI or Aedes aegypti thrombin 
inhibitor (41,42).
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Anti-inflammatories and immunomodulators
Studies and isolations of these types of compounds have been carried 
out, for the most part, with the saliva of ticks, since these arthropods 
remain close to the host for several days and have developed potent 
anti-inflammatory and immunomodulatory compounds. By means 
of these compounds, ticks manage to delay the immune response of 
the host vertebrate and, thus, prolong their feeding.
The most studied compounds are anti-complement compounds 
such as the saliva of Ixodes scapularis or Isac (43), the IRAC I and 
IRAC II proteins found in Ixodes ricinus, which inhibit the alternative 
complement pathway (44), and the salivary protein 20 found in Ixodes 
scapularis or SaIp20, which acts by dissociating C3 convertase (45).
Another site of action is the effect on cells of the immune system. 
For example, the saliva of Ixodes dammini inhibits the functionality of 
neutrophils (46), whereas Dermacentor reticulatus and Ixodes ricinus 
suppress the functions of NK cells, the production of interferon and 
interleukins (47,48), and the proliferation of lymphocytes (49,50). 
Salivary extracts of Amblyomma americanum and Dermacentor 
variabilis ticks are also capable of affecting the proliferation, 
migration and phagocytosis of macrophages (51,52). In addition, the 
maturation of dendritic cells is inhibited by the saliva of Rhipicephalus 
sanguineus (53).
On the other hand, the saliva of some ticks has shown an important 
effect on chemotaxis, the production of various cytokines and the 
modification of the Th1 and Th2 response (54,55). It also has the 
ability to interfere in healing since it hinders fibroblast migration, 
decreases the production of growth factors and the formation of the 
cellular cytoskeleton (56,57), and alters angiogenesis —which is 
product of the effect of the calreticulin protein (54) found in the saliva 
of Ixodes Scapularis and Amblyomma americanum (58).
The Trypansoma brucei vector —producer of American 
trypanosomiasis and found in the saliva of Glossina morsitans— has 
a peptide named Gloss 2 which inhibits the secretion of TNF-α factor, 
IFN-γ and IL-6, apart from affecting the humoral immune response 
by inhibiting the production of IL-10 (59).
Anesthetics
Little has been studied about the anesthetic effect of the saliva of 
hematophagous insects. However, the presence of mechanisms 
through which pain is blocked have been proposed, since many of 
such insects are big, produce a non-painful sting and can suck blood 
for long periods of time without being perceived.
Regarding this hypothesis, there is a study that shows that the 
saliva of Triatoma infestans, the main vector of Trypanosoma cruzi 
in the southern cone of South America, has an inhibitory effect on 
nerve transmission, as it achieves a progressive reduction of the 
action potential amplitude on a rat sciatic nerve model. In the same 
study, an inhibition of sodium-dependent voltage channels in cultures 
of neuronal GH3 cells was demonstrated, leading to hypothesize 
that the saliva of these insects may decrease the generation and 
conduction of nerve action potential, similar to local anesthetics 
currently used (60).
Pharmacological usefulness
One of the best examples of pharmacological use of compounds 
derived from the saliva of hematophagous insects is the development 
of direct thrombin inhibitors: bivalirudin, argatroban and desirudin, 
derivatives of the Hirudin anticoagulant peptide obtained from the 
saliva of the leech Hirudo medicinalis (61). 
The Maxadilan peptide, found in the saliva of Lutzomyia 
longipalpis, is a potent agonist vasodilator specific for the PACAP 
type I receptor, which is widely distributed in the brain. In a study 
with rabbits, this compound was useful for the management of 
cerebral spasms secondary to subarachnoid hemorrhage (62). In 
addition to its vasodilatory effect, its influence on the metabolic 
level has also been observed, since prolonged administration in 
murine models increases insulin sensitivity and lowers basal plasma 
glucose (63). Likewise, Maxadilan has been shown to prevent 
apoptosis of human pluripotent cells by regulating caspases 3 and 
6, without affecting the karyotype or pluripotent state of insect 
cells (64). 
Two molecules are involved in clot formation. One of them 
is simplagrin, found in Simulium nigrimanum, which inhibits the 
interaction of the von Willebrand factor with type III collagen by 
specifically and completely blocking platelet adhesion under high 
flux conditions —it has been proven useful in inhibiting the formation 
of carotid thrombi in mice (65). The other is aegeptin, which binds 
to collagen and inhibits platelet aggregation to soluble or fibrillar 
collagen and the interaction of the Von Willebrand factor (66).
Considering the properties of tick saliva to inhibit cell migration 
and healing, a study on osteosarcoma tumor cells and breast cancer 
was performed, finding that saliva had an inhibitory effect on the 
migration and metastatic invasion of these cells (67).
Conclusions
This review has explored how hematophagous insects have an important 
variety of molecules capable of acting on hemostasis, immunity and 
response to vertebrate pain, thus ensuring their engorging. Similarly, 
different compounds are being investigated for pharmacological use 
in circulatory, metabolic and even oncological pathologies. 
All this leads to conclude that the saliva of hematophagous insects 
offers a great source of research and incalculable potential for the 
discovery of new compounds that could become pharmacologically 
useful and even provide valuable medical alternatives for humanity.
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